Hospital Lusíadas Lisboa

Lisbon 1500-458

1 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Extrapulmonary Neuroendocrine Cancer (epNEC)

Studies at this site

• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling